tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Technical Analysis

704 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
3Neutral
7Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Immunovant is a Sell.
Immunovant’s (IMVT) 20-Day exponential moving average is 29.86, while Immunovant’s (IMVT) share price is $30.7, making it a Buy.
Immunovant’s (IMVT) 50-Day exponential moving average is 30.84, while Immunovant’s (IMVT) share price is $30.7, making it a Sell.

Immunovant (IMVT) Pivot Points

May 18, 2024, 01:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
29.60
30.00
30.74
31.14
31.88
32.28
33.02
Fibonacci
30.00
30.44
30.70
31.14
31.58
31.84
32.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

May 18, 2024, 01:12 PM
Period
Simple
Exponential
MA5
30.69Buy
30.66Buy
MA10
30.16Buy
30.20Buy
MA20
29.19Buy
29.86Buy
MA50
30.24Buy
30.84Sell
MA100
34.36Sell
32.09Sell
MA200
32.68Sell
30.27Buy
Immunovant’s (IMVT) 10-Day exponential moving average is 30.20, while Immunovant’s (IMVT) share price is $30.7, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 32.09, while Immunovant’s (IMVT) share price is $30.7, making it a Sell.
Immunovant’s (IMVT) stock price is $30.7 and Immunovant’s (IMVT) 50-day simple moving average is 30.24, creating a Buy signal.
Immunovant’s (IMVT) stock price is $30.7 and Immunovant’s (IMVT) 100-day simple moving average is 34.36, creating a Sell signal.
Immunovant’s (IMVT) stock price is $30.7 and Immunovant’s (IMVT) 200-day simple moving average is 32.68, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

May 18, 2024, 01:12 PM
Name
Value
Implied Action
RSI (14)
55.93
Neutral
STOCH (9,6)
71.10
Neutral
STOCHRSI (14)
81.38
Sell
MACD (12,26)
0.15
Sell
ADX (14)
19.98
Buy
Williams %R
-25.13
Buy
CCI (14)
123.34
Sell
ATR (14)
1.31
-
Ultimate Oscillator
55.31
Neutral
ROC
11.68
Buy
Immunovant’s (IMVT) Relative Strength Index (RSI) is 55.93, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 19.98, creating a Buy signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is 123.34, creating a Sell signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is 11.68, creating a Buy signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Buy.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 55.93, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is 0.15, which suggests IMVT is a Sell.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 30.69, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 29.19, which suggests IMVT is a Buy.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 30.24, which suggests IMVT is a Buy.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 32.68, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -25.13, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is 123.34, which suggests IMVT is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis